Skip to main content
. 2007 May 8;96(11):1723–1728. doi: 10.1038/sj.bjc.6603785

Figure 1.

Figure 1

VEGFR1 mRNA expression in peripheral blood from gastric cancer cases. Group 1 consisted of noncancer patients (n=16). Group 2 consisted of early cancer patients, with tumours that invaded less than the sub-mucosal layer (n=30). Group 3 consisted of advanced cancer patients, where there was evidence of deep invasion beyond the muscularis propria and no preoperative distant metastasis (n=30). Group 4 was the metastasis and recurrence patient group, where there were distant metastases at the time of operation (i.e., liver and/or lung metastasis, peritoneal dissemination) and who developed postoperative recurrence (e.g., peritoneal dissemination and distant metastasis) (n=30). The mean expression level of VEGFR1 mRNA in group 4 was significantly higher than all other groups (P<0.0001, respectively).